- Home
- LGHL vs EYEN Comparison
LGHL vs EYEN Comparison
Compare LGHL & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGHL
- EYEN
- Stock Information
- Founded
- LGHL 2015
- EYEN 2014
- Country
- LGHL Singapore
- EYEN United States
- Employees
- LGHL N/A
- EYEN N/A
- Industry
- LGHL Investment Bankers/Brokers/Service
- EYEN Biotechnology: Pharmaceutical Preparations
- Sector
- LGHL Finance
- EYEN Health Care
- Exchange
- LGHL Nasdaq
- EYEN Nasdaq
- Market Cap
- LGHL 4.3M
- EYEN 3.7M
- IPO Year
- LGHL N/A
- EYEN 2018
- Fundamental
- Price
- LGHL $3.50
- EYEN $1.18
- Analyst Decision
- LGHL
- EYEN Hold
- Analyst Count
- LGHL 0
- EYEN 4
- Target Price
- LGHL N/A
- EYEN $2.00
- AVG Volume (30 Days)
- LGHL 61.8K
- EYEN 495.7K
- Earning Date
- LGHL 04-29-2025
- EYEN 05-14-2025
- Dividend Yield
- LGHL N/A
- EYEN N/A
- EPS Growth
- LGHL N/A
- EYEN N/A
- EPS
- LGHL N/A
- EYEN N/A
- Revenue
- LGHL $13,659,110.00
- EYEN $31,832.00
- Revenue This Year
- LGHL N/A
- EYEN $23,413.60
- Revenue Next Year
- LGHL N/A
- EYEN $400.98
- P/E Ratio
- LGHL N/A
- EYEN N/A
- Revenue Growth
- LGHL 11.24
- EYEN 2557.09
- 52 Week Low
- LGHL $2.82
- EYEN $1.06
- 52 Week High
- LGHL $43.00
- EYEN $124.80
- Technical
- Relative Strength Index (RSI)
- LGHL 32.32
- EYEN 26.42
- Support Level
- LGHL $2.82
- EYEN $1.06
- Resistance Level
- LGHL $4.89
- EYEN $1.76
- Average True Range (ATR)
- LGHL 0.63
- EYEN 0.10
- MACD
- LGHL -0.07
- EYEN 0.05
- Stochastic Oscillator
- LGHL 25.37
- EYEN 10.51
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.